CHINESE JOURNAL OF MEDICINAL GUIDE ›› 2026, Vol. 28 ›› Issue (2): 135-135-140.doi: 10.1009-0959.2026.030003

Previous Articles     Next Articles

Demand Profile Analysis and System Construction of Pharmacovigilance Talents under the Policy Background of New Quality Productive Forces

ZHANG Meizhen1， LIU Pengcheng2*， CHEN Lei3   

  1. 1.School of Continuing Education， China Pharmaceutical University， Jiangsu Nanjing 210009， China；
    2.School of International Pharmaceutical Business， China Pharmaceutical University， Jiangsu Nanjing 210009， China；
    3.Anhui Ailead Pharmaceutical Co.， Ltd.， Anhui Anqing 246005， China
  • Received:2025-04-22 Revised:2025-10-02 Accepted:2026-03-18 Online:2026-02-28 Published:2026-03-19

PDF (PC)

33

Abstract:

Pharmacovigilance is crucial for the timely identification， assessment， and prevention of adverse drug reactions， serving as a critical safeguard for public medication safety and public health protection. Under the background of new quality productive forces and in line with the upgrade strategy of biopharmaceutical industry， China’s drug regulatory authorities are advancing the internationalization of regulatory systems and innovative models to accelerate the iterative upgrades in pharmaceutical innovation and R&D capabilities. This study focuses on the demand for pharmacovigilance talents in China's pharmaceutical enterprises under the policy background of new quality productive forces. Taking the pharmacovigilance practitioners from 324 pharmaceutical enterprises as samples， this study analyzes their characteristics and finds that pharmacovigilance， as the core of drug full life cycle risk management， faces prominent talent shortages. While professionals with pharmaceutical science backgrounds constitute a relatively high proportion of current pharmacovigilance personnel， the integration of drug safety monitoring with international pharmacoepidemiology requires significant strengthening. Three major constraints affecting pharmacovigilance talent demand are policy regulations， industry development， and technological advancement. Constructing the pharmacovigilance talent system faces challenges including regulatory adaptation， multidisciplinary integration， supply-demand balance， and innovation capacity. It is suggested that by strengthening policy guidance and fostering multi-stakeholder collaboration among industry， academia， education and application to build a high-quality， stable pharmacovigilance talent pipeline， so as to meet the talent demands for high-quality and innovative development in the pharmaceutical industry and ensure public medication safety.


Key words:  , Pharmacovigilance； , New quality productive forces； , Talent demand； , Innovation； , Internationalization

CLC Number: